BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  Rocket Pharmaceuticals Prices Public Offering of Common Stock

  Rocket today announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at a public offering price of $13.25 per share.

  January 24, 2018

   · 

  5 min read
• Biotech Beach

  GT Biopharma Issues Letter to Shareholders

  GT Biopharma today announced that Executive Chairman Anthony Cataldo has issued the following letter to shareholders.

  January 24, 2018

   · 

  8 min read
• Pharm Country

  Migraine Abortion Trial Shows Positive Results for Cefaly Acute Medical Device

  The Cefaly Acute medical device, cleared by the FDA two months ago for the acute treatment of migraine with or without aura, was also successful in a recent trial for migraine abortion.

  January 24, 2018

   · 

  4 min read
• 

  Genetown

  Pfizer’s Biosimilar of Biogen, Roche’s Rituxan Meets Main Goal in Study

  The trial demonstrated equivalence in overall response rate for the first-line treatment of patients with CD20-positive, low tumor burden, follicular lymphoma.

  January 24, 2018

   · 

  5 min read